Most serious illnesses in India are found too late. Heart disease, cancer and metabolic conditions usually announce themselves only when symptoms appear, by which time treatment is harder, costlier and less certain. A Bengaluru company is built around a different starting point: look at the whole body, in depth, while the person still feels perfectly well — and catch what is quietly going wrong years before it becomes a crisis.
The company is Cent, founded in 2025 by Shashank ND, the founder of Practo, together with Anshul Khandelwal, formerly chief marketing officer at Ola Electric, and Arpit Garg, formerly product head at Lenskart. Cent calls itself a preventive health intelligence platform, and its flagship offering is Cent Check: a single, roughly two-hour visit that puts a member through a full-body MRI, a low-dose cardiac CT, a DEXA scan, an ECG and an echocardiogram, plus more than 100 blood and urine biomarkers, all under the company’s proprietary CCNM protocol — cardiac, cancer, neurological and metabolic screening in one flow.
A Cent centre scanner room, where full-body imaging sits at the heart of the screening visit.
The idea is to replace the fragmented annual check-up with one standardised, purpose-built visit. Instead of tests scattered across different labs and hospitals, each with its own format, Cent runs its own centres — a 7,000 sq. ft. flagship opened in Bengaluru in April 2026, with centres in Mumbai and Delhi-NCR following — designed from the ground up as single-purpose prevention centres. The company says its AI brings every result together into one picture of the body, specialist doctors review each finding, and members leave with a doctor-led plan and support through the year. The screening is synthesised into an AI-led, organ-level risk report — Cent calls it Tru10 — followed by a physician consultation, all within the two-hour window.
That depth is the point. Routine blood tests, the company says, miss what imaging can see: a tumour still too small to feel, an artery quietly narrowing, an aneurysm waiting unnoticed. Cent’s protocol is designed to screen for more than 300 health risks, and the company has deepened a partnership with Siemens Healthineers to power its imaging — a collaboration that goes beyond equipment supply into co-developing preventive imaging protocols and deploying software to improve scan efficiency and diagnostic accuracy, with the aim of bringing costs down as the network scales.
More Read
A Cent preventive health centre, built as a dedicated space for early detection rather than a general diagnostic lab.
The early numbers show why the founders believe the shift matters. The company says it has now completed 10,000 preventive whole-body scans across Bengaluru, Mumbai and Delhi-NCR, and among members who felt well when they walked in, one in four had a finding worth acting on, while one in 40 needed immediate medical attention — including early-stage tumours, significantly narrowed arteries and aneurysms. Every scan also adds to a growing dataset on the health of asymptomatic Indians, which the company says it will use to build Indian baselines for a healthy body, train models that flag disease risk earlier, and support clinical research.
Growth is now accelerating. On 27 October 2026 Cent announced a $15 million Series A round, a mix of equity and debt co-led by Blume Ventures and existing investor South Park Commons, with participation from individual investors including former Vodafone chief executive Arun Sarin and former OpenAI business-to-business chief technology officer Srinivas Narayanan. The company says the capital will go into research and development and into expanding its AI, engineering and clinical teams. Alongside the round, Cent acquired Medsee, an AI-powered radiology reporting workflow platform founded by Chitra Singh, which drafts structured reports and highlights findings for review by qualified radiologists — the engine, the company says, for faster and more consistent reporting as scan volumes climb.
The ambition is deliberately large: 10 million scans by 2035, and one million lives saved through early detection, with expansion planned to 15 cities across India. For a country where, by figures cited by the company, an estimated 101 million people live with diabetes, 136 million with prediabetes and around 315 million with hypertension, the promise of Cent is simple and quietly radical — that the most powerful moment in healthcare is not the treatment that follows a diagnosis, but the scan that finds the problem before the patient ever feels ill.
Keep reading: A Few Drops of Serum, an Answer in Minutes: Inside Inflanova’s Paper-Strip Test for Osteoporosis Risk · Killing Germs Mid-Air: Inside Biomoneta, the Bengaluru Startup Turning Hospital Air Into a Germ Trap · More Chemicals, Materials & Life Sciences stories
Like stories like this? Add Exceptional Technology as a preferred source on Google to see more of our reporting in your search results and Discover feed.
